Watson Pharmaceuticals Inc.

Watson Pharmaceuticals says FDA approves 6-month dose of prostate cancer drug TrelstarWatson Pharmaceuticals Inc. said the Food and Drug Administration approved a six-month dose of the prostate cancer drug Trelstar, which already was available in one- and three-month doses. Trelstar is developed ...